BMO Capital on Exelixis (EXEL): 'we do not expect a cabo generic entry by MSN until at least the latest...'
Tweet Send to a Friend
BMO Capital analyst Etzer Darout reiterated an Outperform rating and $29.00 price target on Exelixis (NASDAQ: EXEL).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
